RASSF1A Inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression

Rosalyn R. Ram, Saurabh Mendiratta, Brian O. Bodemann, Michael J. Torres, Ugur Eskiocak, Michael A. White

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The RASSF1A gene is one of the most frequently inactivated genes in over 30 different types of cancers (H. Donninger, M. D. Vos, and G. J. Clark, J. Cell Sci. 120:3163-3172, 2007, http://dx.doi.org/10.1242/jcs.010389). Despite the prevalence of RASSF1A silencing in human cancer, the mechanism by which RASSF1A functions as a tumor suppressor is not well understood. Characterization of the consequences of RASSF1A loss on epithelial cell proliferation revealed that RASSF1A expression suppresses both microRNA 21 (miR-21) expression and extracellular signal-regulated kinase 1/2 (ERK1/2) activation. The mechanism of the former is through restraint of SCFβTrCP-dependent destruction of the repressor element 1 silencing transcription factor (REST) tumor suppressor and consequent inhibition of miR-21 promoter activation. The mechanism of the latter is through physical sequestration of MST2, which results in accumulation of inactivating S259 phosphorylation of RAF1. Whether or not inactivation of these RASSF1A regulatory relationships can unleash enhanced proliferative capacity is dependent upon the coupling of SCFβTrCP and miR-21 to suppression of SKP2 protein translation and stability. Airway epithelial cultures retain this coupling and therefore respond to RASSF1A inactivation by p27-dependent cell cycle arrest. In contrast, colonic crypt-derived epithelial cells have uncoupled SCFβTrCP from SKP2 and respond to RASSF1A inactivation by enhanced proliferation rates. These observations help account for context-specific molecular etiology of oncogenic transformation and suggest intervention strategies for recently developed SKP2 inhibitors.

Original languageEnglish (US)
Pages (from-to)2350-2358
Number of pages9
JournalMolecular and Cellular Biology
Volume34
Issue number12
DOIs
StatePublished - 2014

Fingerprint

Oncogenes
Cell Cycle
MicroRNAs
Neoplasms
Epithelial Cells
Transcriptional Silencer Elements
Mitogen-Activated Protein Kinase 3
Protein Stability
Mitogen-Activated Protein Kinase 1
Protein Biosynthesis
Cell Cycle Checkpoints
Genes
Transcription Factors
Phosphorylation
Cell Proliferation

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

RASSF1A Inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression. / Ram, Rosalyn R.; Mendiratta, Saurabh; Bodemann, Brian O.; Torres, Michael J.; Eskiocak, Ugur; White, Michael A.

In: Molecular and Cellular Biology, Vol. 34, No. 12, 2014, p. 2350-2358.

Research output: Contribution to journalArticle

Ram, Rosalyn R. ; Mendiratta, Saurabh ; Bodemann, Brian O. ; Torres, Michael J. ; Eskiocak, Ugur ; White, Michael A. / RASSF1A Inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression. In: Molecular and Cellular Biology. 2014 ; Vol. 34, No. 12. pp. 2350-2358.
@article{52c18477e6444e818ba586565aa923d9,
title = "RASSF1A Inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression",
abstract = "The RASSF1A gene is one of the most frequently inactivated genes in over 30 different types of cancers (H. Donninger, M. D. Vos, and G. J. Clark, J. Cell Sci. 120:3163-3172, 2007, http://dx.doi.org/10.1242/jcs.010389). Despite the prevalence of RASSF1A silencing in human cancer, the mechanism by which RASSF1A functions as a tumor suppressor is not well understood. Characterization of the consequences of RASSF1A loss on epithelial cell proliferation revealed that RASSF1A expression suppresses both microRNA 21 (miR-21) expression and extracellular signal-regulated kinase 1/2 (ERK1/2) activation. The mechanism of the former is through restraint of SCFβTrCP-dependent destruction of the repressor element 1 silencing transcription factor (REST) tumor suppressor and consequent inhibition of miR-21 promoter activation. The mechanism of the latter is through physical sequestration of MST2, which results in accumulation of inactivating S259 phosphorylation of RAF1. Whether or not inactivation of these RASSF1A regulatory relationships can unleash enhanced proliferative capacity is dependent upon the coupling of SCFβTrCP and miR-21 to suppression of SKP2 protein translation and stability. Airway epithelial cultures retain this coupling and therefore respond to RASSF1A inactivation by p27-dependent cell cycle arrest. In contrast, colonic crypt-derived epithelial cells have uncoupled SCFβTrCP from SKP2 and respond to RASSF1A inactivation by enhanced proliferation rates. These observations help account for context-specific molecular etiology of oncogenic transformation and suggest intervention strategies for recently developed SKP2 inhibitors.",
author = "Ram, {Rosalyn R.} and Saurabh Mendiratta and Bodemann, {Brian O.} and Torres, {Michael J.} and Ugur Eskiocak and White, {Michael A.}",
year = "2014",
doi = "10.1128/MCB.01506-13",
language = "English (US)",
volume = "34",
pages = "2350--2358",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - RASSF1A Inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression

AU - Ram, Rosalyn R.

AU - Mendiratta, Saurabh

AU - Bodemann, Brian O.

AU - Torres, Michael J.

AU - Eskiocak, Ugur

AU - White, Michael A.

PY - 2014

Y1 - 2014

N2 - The RASSF1A gene is one of the most frequently inactivated genes in over 30 different types of cancers (H. Donninger, M. D. Vos, and G. J. Clark, J. Cell Sci. 120:3163-3172, 2007, http://dx.doi.org/10.1242/jcs.010389). Despite the prevalence of RASSF1A silencing in human cancer, the mechanism by which RASSF1A functions as a tumor suppressor is not well understood. Characterization of the consequences of RASSF1A loss on epithelial cell proliferation revealed that RASSF1A expression suppresses both microRNA 21 (miR-21) expression and extracellular signal-regulated kinase 1/2 (ERK1/2) activation. The mechanism of the former is through restraint of SCFβTrCP-dependent destruction of the repressor element 1 silencing transcription factor (REST) tumor suppressor and consequent inhibition of miR-21 promoter activation. The mechanism of the latter is through physical sequestration of MST2, which results in accumulation of inactivating S259 phosphorylation of RAF1. Whether or not inactivation of these RASSF1A regulatory relationships can unleash enhanced proliferative capacity is dependent upon the coupling of SCFβTrCP and miR-21 to suppression of SKP2 protein translation and stability. Airway epithelial cultures retain this coupling and therefore respond to RASSF1A inactivation by p27-dependent cell cycle arrest. In contrast, colonic crypt-derived epithelial cells have uncoupled SCFβTrCP from SKP2 and respond to RASSF1A inactivation by enhanced proliferation rates. These observations help account for context-specific molecular etiology of oncogenic transformation and suggest intervention strategies for recently developed SKP2 inhibitors.

AB - The RASSF1A gene is one of the most frequently inactivated genes in over 30 different types of cancers (H. Donninger, M. D. Vos, and G. J. Clark, J. Cell Sci. 120:3163-3172, 2007, http://dx.doi.org/10.1242/jcs.010389). Despite the prevalence of RASSF1A silencing in human cancer, the mechanism by which RASSF1A functions as a tumor suppressor is not well understood. Characterization of the consequences of RASSF1A loss on epithelial cell proliferation revealed that RASSF1A expression suppresses both microRNA 21 (miR-21) expression and extracellular signal-regulated kinase 1/2 (ERK1/2) activation. The mechanism of the former is through restraint of SCFβTrCP-dependent destruction of the repressor element 1 silencing transcription factor (REST) tumor suppressor and consequent inhibition of miR-21 promoter activation. The mechanism of the latter is through physical sequestration of MST2, which results in accumulation of inactivating S259 phosphorylation of RAF1. Whether or not inactivation of these RASSF1A regulatory relationships can unleash enhanced proliferative capacity is dependent upon the coupling of SCFβTrCP and miR-21 to suppression of SKP2 protein translation and stability. Airway epithelial cultures retain this coupling and therefore respond to RASSF1A inactivation by p27-dependent cell cycle arrest. In contrast, colonic crypt-derived epithelial cells have uncoupled SCFβTrCP from SKP2 and respond to RASSF1A inactivation by enhanced proliferation rates. These observations help account for context-specific molecular etiology of oncogenic transformation and suggest intervention strategies for recently developed SKP2 inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=84901322733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901322733&partnerID=8YFLogxK

U2 - 10.1128/MCB.01506-13

DO - 10.1128/MCB.01506-13

M3 - Article

VL - 34

SP - 2350

EP - 2358

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 12

ER -